D Path’s QPOR™ Platform Selected to Predict Patients’ Responses to TherapyNEWTON, Mass., Jan. 22, 2026 (GLOBE NEWSWIRE) -- 4D ...
Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced publication of a landmark study in the ...
The phase 2a trial showed GR-0621 met primary and secondary endpoints, demonstrating safety and efficacy over 12 weeks. Phase 2a data show oral GRI-0621 was safe and improved immune and fibrosis ...
Trastuzumab-based regimens were the primary treatment for older adults with advanced HER2-positive gastric cancer before immunotherapy became standard. The study highlights substantial economic ...
“This publication validates our belief that precision medicine should be measured, not marketed,” said Katy Whalen, ...
Hosted on MSN
Study identifies promising biomarker for early sepsis detection in neonates, children and pregnant women
A study presented at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient groups, including ...
In patients with cystic fibrosis, CMTX-101, an immune-enabling antibody therapy, lowered four inflammatory biomarkers and ...
The ratio between two signaling molecules may be a key marker of MS brain inflammation and help identify candidates for BTK inhibitors.
16don MSN
Simple at-home finger prick blood test enables accurate detection of Alzheimer's biomarkers: study
Simple finger-prick blood samples that can be collected at home and mailed to laboratories without refrigeration or prior processing can help detect Alzheimer's disease biomarkers accurately.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback